HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target.

AbstractRESEARCH QUESTION:
Is the hypusinated form of the eukaryotic translation initiation factor 5A (EIF5A) present in human myometrium, leiomyoma and leiomyosarcoma, and does it regulate cell proliferation and fibrosis?
DESIGN:
The hypusination status of eIF5A in myometrial and leiomyoma patient-matched tissues was evaluated by immunohistochemistry and Western blotting as well as in leiomyosarcoma tissues by immunohistochemistry. Myometrial, leiomyoma and leiomyosarcoma cell lines were treated with N1-guanyl-1,7-diaminoheptane (GC-7), responsible for the inhibition of the first step of eIF5A hypunization, and the proliferation rate was determined by MTT assay; fibronectin expression was analysed by Western blotting. Finally, expression of fibronectin in leiomyosarcoma tissues was detected by immunohistochemistry.
RESULTS:
The hypusinated form of eIF5A was present in all tissues examined, with an increasing trend of hypusinated eIF5A levels from normal myometrium to neoplastic benign leiomyoma up to neoplastic malignant leiomyosarcoma. The higher levels in leiomyoma compared with myometrium were confirmed by Western blotting (P = 0.0046). The inhibition of eIF5A hypusination, with GC-7 treatment at 100 nM, reduced the cell proliferation in myometrium (P = 0.0429), leiomyoma (P = 0.0030) and leiomyosarcoma (P = 0.0044) cell lines and reduced the expression of fibronectin in leiomyoma (P = 0.0077) and leiomyosarcoma (P = 0.0280) cells. The immunohistochemical staining of leiomyosarcoma tissue revealed that fibronectin was highly expressed in the malignant aggressive (central) part of the leiomyosarcoma lesion, where hypusinated eIF5A was also highly represented.
CONCLUSIONS:
These data support the hypothesis that eIF5A may be involved in the pathogenesis of myometrial benign and malignant pathologies.
AuthorsStefania Greco, Alessandro Zannotti, Pamela Pellegrino, Federica Giantomassi, Giovanni Delli Carpini, Mattia D'Agostino, Gaia Goteri, Andrea Ciavattini, Chiara Donati, Caterina Bernacchioni, Felice Petraglia, Anna La Teana, Pasquapina Ciarmela
JournalReproductive biomedicine online (Reprod Biomed Online) Vol. 47 Issue 1 Pg. 15-25 (07 2023) ISSN: 1472-6491 [Electronic] Netherlands
PMID37137790 (Publication Type: Journal Article)
CopyrightCopyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Fibronectins
Topics
  • Female
  • Humans
  • Fibronectins (metabolism)
  • Leiomyosarcoma (metabolism, pathology)
  • Leiomyoma (pathology)
  • Cell Proliferation
  • Myometrium (metabolism)
  • Uterine Neoplasms (pathology)
  • Eukaryotic Translation Initiation Factor 5A

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: